Biotech company Alnylam Pharmaceuticals conceded defeat for now in a lawsuit against Pfizer and BioNTech over technology in ...

The University of California and the University of Vienna on Monday convinced a U.S. appeals court to revive their bid for ...

There’s always been a lot of confusion over whether you can patent video games. So, can you? The short answer is yes. In fact ...

Tesla Inc. supplier Solus Advanced Materials Co. failed to convince an East Texas federal judge to transfer or pause SK ...

Stark, J. Sage Products, LLC (“Sage”) challenged a Patent Trial and Appeal Board (“Board”) decision finding two of Sage’s patents unpatentable.

The Trade-Adverse Trade Adviser: Once sidelined, President Trump’s counselor Peter Navarro has returned to Washington and ...

Opinion: Sterne Kessler’s Dohm Chankong and Richard Coller tell the medical device industry to look back and learn from ...

DraftKings, the company behind the in-play betting app of the same name, is being sued over its “micro-betting.” Micro-Gaming ...

With potentially huge sums at stake, a federal court on Monday reinstated UC Berkeley’s legal claim seeking nationwide rights to develop and market gene editing, the transfer of genetic technology ...

The U.S. Government Accountability Office (GAO) has issued a sharply critical report concluding that the United States Patent ...

Kirkpatrick noted that the company continues to work on the development of its lead product, PF614, an extended-release oxycodone to treat severe pain, as well as its combination product, PF614-MPAR, ...

This week, we take a closer look at two precedential cases concerning pharmaceutical patent protections as applied to drugs in development.